Photo of Anthony Philippakis

Anthony Philippakis

Venture Partner

We’ve seen tremendous breakthroughs in genomic science in the past five years, especially as vast quantities of genomic data become available, and the costs of sequencing fall. In my role as chief data officer at the Broad Institute of MIT and Harvard, my team manages more than 100 petabytes of data. We’re finally hitting an inflection point where this data is being applied to create diagnostic tools and therapeutic interventions. These real-world applications will have a major impact on the lives of patients, especially as we get closer to using data to make better decisions about healthcare.